Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TransMedics (TMDX) Current Assets (2018 - 2025)

TransMedics (TMDX) has 8 years of Current Assets data on record, last reported at $637.8 million in Q4 2025.

  • For Q4 2025, Current Assets rose 28.27% year-over-year to $637.8 million; the TTM value through Dec 2025 reached $637.8 million, up 28.27%, while the annual FY2025 figure was $637.8 million, 28.27% up from the prior year.
  • Current Assets reached $637.8 million in Q4 2025 per TMDX's latest filing, up from $613.0 million in the prior quarter.
  • Across five years, Current Assets topped out at $662.7 million in Q2 2023 and bottomed at $95.1 million in Q2 2022.
  • Average Current Assets over 5 years is $374.9 million, with a median of $490.4 million recorded in 2024.
  • Peak YoY movement for Current Assets: fell 29.57% in 2022, then skyrocketed 596.7% in 2023.
  • A 5-year view of Current Assets shows it stood at $118.7 million in 2021, then soared by 112.54% to $252.3 million in 2022, then soared by 102.4% to $510.7 million in 2023, then fell by 2.63% to $497.2 million in 2024, then increased by 28.27% to $637.8 million in 2025.
  • Per Business Quant database, its latest 3 readings for Current Assets were $637.8 million in Q4 2025, $613.0 million in Q3 2025, and $558.1 million in Q2 2025.